Concepedia

Françoise Tiberghien

FT

Statistics

Publications

5

Citations

360

H-Index

5

Active since

1996

Affiliations

Novartis (Switzerland)(Current)

Université de Strasbourg

Françoise Tiberghien is an author at Novartis (Switzerland) specializing in bioanalysis, drug development, and high-throughput screening.

Top concepts

Publications per year

1996–2002

5

Publications

5

Ranking of P-glycoprotein substrates and inhibitors by a calcein-AM fluorometry screening assay

Françoise Tiberghien, Francis Loor · Anti-Cancer Drugs · 1996 · 186 citations · Full text

, , +20

Aureobasidins:  Structure−Activity Relationships for the Inhibition of the Human <i>MDR1</i> P-Glycoprotein ABC-Transporter

Françoise Tiberghien, Toru Kurome, Kazutoh Takesako et al. · Journal of Medicinal Chemistry · 2000 · 65 citations · Full text

Cyclosporins:  Structure−Activity Relationships for the Inhibition of the Human <i>MDR1</i> P-Glycoprotein ABC Transporter

Francis Loor, Françoise Tiberghien, Tom Wenandy et al. · Journal of Medicinal Chemistry · 2002 · 56 citations

Cyclosporins:  Structure−Activity Relationships for the Inhibition of the Human <i>FPR1</i> Formylpeptide Receptor

Francis Loor, Françoise Tiberghien, Tom Wenandy et al. · Journal of Medicinal Chemistry · 2002 · 36 citations · Full text

The Potent Immunosuppressive Cyclosporin FR901459 Inhibits the Human P-Glycoprotein and Formyl Peptide Receptor Functions.

Françoise Tiberghien, Tom Wenandy, Francis Loor · The Journal of Antibiotics · 2000 · 17 citations · Full text

1–5 of 5